Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Tolvaptan 60 mg + 30mg tablets {equilateral_black_triangle}

Active Ingredient:
tolvaptan
Company:  
Zentiva See contact details
ATC code: 
C03XA01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Tolvaptan HCP prescribing checklist for treatment initiation

{healthcare_pro_orange} For Healthcare Professionals

Tolvaptanā–¼ Healthcare Professional (HCP) prescribing checklist for treatment initiation

{pdf_link}

Tolvaptan Patient Alert Card

Patient Alert Card

{pdf_link}

Tolvaptan Patient/Carer Brochure

Important safety information on hepatotoxicity for patients and carers

{pdf_link}

Tolvaptan Zentiva Healthcare Professional Educational Guide

{healthcare_pro_orange} For Healthcare Professionals

Important information on minimising the risk of hepatotoxicity.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Zentiva
Company image
Address
First Floor, Andrews House, College Road, Guildford, Surrey, GU1 4QB, UK
Medical Information Direct Line
+44 (0)800 090 2408
Customer Care direct line
+44 (0)844 8793 188
E-mail
[email protected]
WWW
https://www.zentiva.co.uk/contact/mi-form
Medical Information e-mail
[email protected]